Capricor Therapeutics Inc
Statements
Cash Flow
Capricor Therapeutics Inc (CAPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -31 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.5 | -4.2 | -4.7 | -3.7 | -3.2 | -2.7 | -3.4 | -3.7 | -3.0 | -3.8 | -1.6 | -1.8 | -1.7 | -1.8 | -1.2 | -2.0 | -3.0 | -3.8 | -3.3 | -4.5 | -3.3 | -5.6 | 24 | -6.5 | -5.7 | -6.9 | 4.2 | -9.4 | -8.8 | -12 | -1.3 | -12 | -12 | -15 | -6.4 | -20 | -20 | -24 | -29 | -31 | -104 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 1,003 | 0.5 | 296 | 1,300 | |
| 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.2 | 0.1 | 0.3 | 0.7 | 0.5 | 0.5 | 0.8 | 0.7 | 0.7 | 0.8 | 1.1 | 1.2 | 1.1 | 1.1 | 2.2 | 1.6 | 1.7 | 1.9 | 3.3 | 2.2 | 2.1 | 2.3 | 5.7 | 3.6 | 7,369 | -3,394 | 5.9 | 9,578 | 13,559 | |
| 0.6 | 2.0 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.2 | 0.1 | 0.3 | 0.7 | 0.5 | 0.5 | 0.8 | 0.4 | 0.7 | 0.9 | 1.2 | 1.1 | 1.6 | 1.6 | 2.2 | 1.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.2 | -1.7 | -1.5 | -0.7 | -0.9 | 0.2 | -0.2 | -0.1 | 0.7 | -0.9 | 0.6 | 0.1 | -0.3 | -0.5 | 0.5 | 0.3 | 0.4 | -0.2 | 1.0 | -0.2 | -0.2 | -0.4 | 31 | -0.7 | -0.6 | -0.5 | 9.6 | -3.9 | -4.4 | -13 | 4.9 | -3.8 | -1.2 | -10 | 12 | 1.7 | 0.0 | -1.2 | -2.0 | 2.0 | -1.2 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 32 | 0.2 | 0.0 | 0.1 | 32 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.3 | 0.0 | 0.3 | 0.5 | 0.4 | 0.6 | 0.4 | 1.1 | 1.2 | 0.5 | 0.2 | 0.6 | 0.7 | 0.7 | 0.1 | 0.1 | 0.7 | 1.1 | 1.4 | 4.0 | 5.1 | 11 | 5.9 | 26 | |
| 0.0 | -11 | 4.0 | 5.0 | -1.0 | -3.0 | 1.8 | 0.0 | -0.1 | 3.0 | 3.0 | -6.0 | -6.0 | -6.0 | 6.0 | -0.1 | -0.2 | -0.3 | 0.0 | -0.3 | -0.5 | -0.4 | -0.6 | -35 | -4.2 | 5.1 | -3.2 | 6.5 | 7.7 | -5.9 | -9.5 | 15 | 2.0 | -123 | 24 | 15 | 16 | 43 | -155 | -49 | -144 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 9.9 | 0.0 | 0.0 | 3.7 | 4.6 | 2.8 | 2.4 | 2.9 | 1.1 | 0.5 | 1.4 | 0.0 | 2.6 | 4.6 | 4.5 | 25 | 2.2 | 1.5 | 13 | 1.0 | – | – | – | – | – | – | 0.0 | 2.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.8 | 4.8 | 0.3 | 0.3 | 0.3 | 0.3 | 0.1 | – | – | – | – | – | 0.3 | 0.3 | 0.3 | 0.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 12 | 16,473 | 0.0 | 3.9 | 4.6 | 3.0 | 2.5 | 2.8 | 1.1 | 0.5 | 1.4 | 0.5 | 2.6 | 4.6 | 4.5 | 25 | 2.2 | 1.5 | 13 | 1.0 | 6.6 | 0.0 | 0.0 | 0.0 | 1.9 | 2.9 | 0.0 | 2.2 | 0.2 | 23 | 2.3 | 2.1 | 67 | 81 | 0.1 | 0.0 | 0.0 | 249 | 1.5 | -4.2 | 246 | |
| 9.2 | -15 | -0.7 | 5.2 | 0.4 | -2.6 | 0.9 | -0.9 | -2.1 | -0.3 | 2.8 | -1.2 | 0.9 | -3.2 | 9.3 | 23 | -1.0 | -2.6 | 9.2 | -3.8 | 2.8 | -6.0 | 23 | -42 | -8.0 | 1.2 | 1.0 | -0.8 | -0.9 | 5.7 | -8.5 | 4.5 | 58 | -57 | 18 | -5.6 | -3.7 | 268 | -182 | -84 | -2.3 | |
| -2.5 | -4.3 | -4.7 | -3.7 | -3.2 | -35 | -3.6 | -3.7 | -3.1 | -36 | -1.6 | -1.8 | -1.7 | -1.8 | -1.2 | -2.1 | -3.1 | -4.1 | -3.4 | -4.8 | -3.8 | -6.0 | 23 | -7.0 | -6.8 | -8.1 | 3.8 | -9.7 | -9.4 | -12 | -1.9 | -12 | -12 | -16 | -7.6 | -22 | -24 | -29 | -40 | -37 | -130 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.